Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 06/13/2016 - 04/20/2019

Target Audience

This course is designed for pharmacists, nurse practitioners or other healthcare professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

Schizophrenia is a chronic illness characterized by positive symptoms, negative symptoms and impairments in neurocognition. Antipsychotics are the mainstay of treatment however we do not yet fully understand the pathophysiology of schizophrenia or if dopamine is a primary neurotransmitter or only as secondary messenger in the etiology of the illness. Environmental factors such as diet and vitamins have been shown to be associated with schizophrenia. This has been found during the illness but also during prenatal development when deficiencies in vitamins may play a key role in neurodevelopment. Growing evidence suggests that vitamin levels are lower in schizophrenia compared to healthy controls. Thus, vitamins may have a role in schizophrenia. Furthermore, accumulating evidence suggests that genetic polymorphisms or subgroup factors that may contribute to greater treatment response for symptoms in people with schizophrenia. This talk will focus on the role of vitamins in schizophrenia and will focus on understanding patient factors that may have a greater treatment response.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • If necessary, complete the post-test retest no later than the closing activity date. (login first)
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.

Participants in this course must complete an examination and achieve a score of 70% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.

Faculty Information and Disclosures

Learning Objectives

  1. Review cross-sectional and epidemiologic studies of vitamin deficiency in schizophrenia.
  2. Understand how vitamin deficiency may contribute to the pathophysiology of schizophrenia.
  3. Discuss evidence for vitamin supplementation in schizophrenia and the role of genetics in treatment response.

Continuing Education Credit and Disclosures

Activity Dates: 06/13/2016 - 04/20/2019
ACPE Contact Hours: 1.0
ACPE Number: 0284-0000-16-023-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 1.0 contact hours (0.1 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is 0284-0000-16-023-H01-P (1.0 contact hours).